Transverse myelitis

References cited
Article section 15 of 16.  Previous  Next

By Anthony T Reder MD

Alarcon SD, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68:353-65.

Albucher JF, Lauque D, Geyer I, et al. Myelite transverse induite par une infection a mycoplasma pneumoniae. Rev Neurol (Paris) 1995;151:350-3.

Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler 2011;17(1):74-80.

Altrocchi PH. Acute transverse myelopathy. Arch Neurol 1963;9:111-9.

Alvarenga MP, Thuler LC, Neto SP, et al. The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol 2010.

Alvord EC Jr. Disseminated encephalomyelitis: its variations in form and their relationships to other diseases of the nervous system. In: Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC, editors. Handbook of clinical neurology. Amsterdam: North Holland, 1985:467-502.

Andersen O. Myelitis. Curr Opin Neurol 2000;13:311-6.

Andronikou S, Albuquerque-Jonathan G, Wilmshurst J, Hewlett R. MRI findings in acute idiopathic transverse myelopathy in children. Pediatr Radiol 2003;33:624-9.

Anlar B, Gucuyener K, Imir T, Yalaz K, Renda Y. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study. Pediatr Infect Dis 1993;12:578-81.

Asherio A, Shumin PH, Zhang M, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-32.

Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 1992;42:85-91.

Austin SG, Zee CS, Waters C. The role of magnetic resonance imaging in acute transverse myelitis. Can J Neurol Sci 1992;19:508-11.

Bakshi R, Kinkel PR, Mechtler LL, et al. Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis. Eur J Neurol 1998;5:35-48.

Barakos JA, Mark AS, Dillon WP, Norman D. MR imaging of acute transverse myelitis and AIDS myelopathy. J Comput Assist Tomogr 1990;14:45-50.

Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992;19:370-2.

Bashir K, Whitaker JN. Importance of paraclinical and CSF studies in the diagnosis of multiple sclerosis patients presenting with partial cervical transverse myelopathy: cranial MRI. Mult Scler 2000;6:312-6.

Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-8.**

Berger Y, Blaivas JG, Oliver L. Urinary dysfunction in transverse myelitis. J Urol 1990;144:103-5.

Berghella V, Spector T, Trauffer P, Johnson A. Pregnancy in patients with preexisting transverse myelitis. Obstet Gynecol 1996;87:809-12.

Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981;31:966-71.

Borchers AT, Gershwin ME. Transverse myelitis. Autoimmun Rev 2012;11(3):231-48.

Bramanti P, Sessa E, Rifici C, et al. Enhanced spasticity in primary progressive multiple sclerosis patients treated with interferon beta-1b. Neurology 1998;51:1720-3.

Byskosh PV, Reder AT. Interferon-beta effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1996;1:262-9.

Cabrera-Gomez JA, Galarraga-Inza J, Coro-Antich RM, et al. Down's syndrome and neuromyelitis optica (Devic's disease): an autopsy-proven case. Mult Scler 2007;13:433-6.

Chahin S, Garwood MD, St Louis EK, Shivapour ET, Kelkar PM, Granner MA. Intramedullary Sjögren syndrome. Neurology 2009;73(23):2041-2.

Chan KH, Tsang KL, Fong GCY, Ho SL, Cheung RTF, Mak W. Idiopathic inflammatory demyelinating disorders after acute transverse myelitis. Eur J Neurol 2006;13:862-8.

Chen L, Li J, Guo Z, Liao S, Jiang L. Prognostic indicators of acute transverse myelitis in 39 children. Pediatr Neurol 2013;49(6):397-400.

Choi KH, Lee KS, Chung SO, et al. Idiopathic transverse myelitis: MR characteristics. Am J Neuroradiol 1996;17(6):1151-60.

Christensen PB, Wermuth L, Hinge HH, Bomers K. Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 1990;81:431-5.

Constantinescu CS. Melanin, melatonin, melanocyte-stimulating hormone, and the susceptibility to autoimmune demyelination: a rationale for light therapy in multiple sclerosis. Med Hypotheses 1995;45(5):455-8.

Cordonnier C, de Seze J, Breteau G, et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 2003;250:1447-52.*

Cree BAC, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64:1270-2.

Dalecky A, Pelletier J, Cherif AA, Levrier O, Khalil R. Myelopathies aigues du sujet jeune et sclerose en plaques: Etude prospective de 20 cas. Rev Neurol 1997;153:569-78.

Debette S, de Sèze J, Pruvo JP, et al. Long-term outcome of acute and subacute myelopathies. J Neurol 2009;256(6):980-8.

Defresne P, Hollenberg H, Husson B, et al. Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 2003;18:401-6.*

DeSanto J, Ross JS. Spine infection/inflammation. Radiol Clin North Am 2011;49(1):105-27.

de Seze J, Lanctin C, Lebrun C, et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 2005;65:1950-3.

de Seze J, Peoc’h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 2002;249:626-7.

Deuskar NJ, Thakare JP, Gore MM, Wadia RS, Ghosh SN. Cerebrospinal fluid immunoglobulins in acute transverse myelitis. Indian J Med Res 1983;77:854-60.

Dodson D. Transverse myelitis and spastic paraparesis in a patient with HIV infection [letter]. N Engl J Med 1990;322:1322.

Donati E, Bargnani C, Besana R, Locatelli P, Faggi L, DeMarinis S. Subacute myelo-optic neuropathy (SMON) induced by antituberculous treatment in uremia. Funct Neurol 1990;5:151-4.

Dowling PC, Bosch VV, Cook SD. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology 1980;30:33-6.

Dunne K, Hopkins IJ, Shield LK. Acute transverse myelopathy in childhood. Dev Med Child Neurol 1986;28:198-204.

Feng X, Reder NP, Yanamandala M, et al. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J Neurol Sci 2012;313(1-2):48-53.

Fenichel GM. Neurological complications of immunization. Ann Neurol 1982;12:119-28.

Foix C, Alajouanine T. La myélite nécrotique subaigue: myélite centrale angéio-hypertrophique à évolution progressive. Paraplégie amyotrophique lentement ascendante, d'abord spasmodique, puis flasque, s'accompagnant de dissociation albumino-cytologique. Rev Neurol 1926;2:3-42.**

Follis AH, Netsky MG. Progressive necrotic myelopathy. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Multiple sclerosis and other demyelinating diseases. New York: Wiley Interscience, 1970:452-68.**

Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992;42:250-2.

Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990;100:217-22.

Garcia-Merino A, Blasco MR. Recurrent transverse myelitis with unusual long-standing Gd-DTPA enhancement. J Neurol 2000;247:550-1.

Goh C, Phal PM, Desmond PM. Neuroimaging in acute transverse myelitis. Neuroimaging Clin N Am 2011;21(4):951-73.**

Goodhart LC, Loizou LA, Anderson M. Heroin myelopathy. J Neurol Neurosurg Psychiatry 1982;45:562-3.

Graber JJ, Allie SR, Mullen KM, et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol 2008;196(1-2):124-32.

Greenberg BM, Thomas, KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Idiopathic transverse myelitis; corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2007;68:1614-17.

Grewal AK, Lopes MB, Berg CL, Bennett AK, Alves VA, Trugman JM. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci 2004;224:101-6.

Group TMCW. (Transverse Myelitis Consortium Working Group). Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59:499-505.

Guidotti M, Passerini D, Brambilla M, Landi G. Heroin myelopathy: a case report. Ital J Neurol Sci 1985;6:99-100.

Gutowski NJ, Davies AO. Transverse myelitis following general anaesthesia. Anaesthesia 1993;48:44-5.

Haase CG, Schmidt S. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic’s neuromyelitis optica. Neurosci Lett 2001;307:131-3.

Hartman E, Reder AT, Bernard J, et al. Spectrum of adverse neurological events with biologic therapies in autoimmune disease. CMSC/ACTRIMS, San Antonio, Texas, June 5, 2010.

Harzheim M, Schlegel U, Urbach H, et al. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 2004;217:217-23.**

Helgason CM, Arnason BW. Demyelinating diseases affecting the spinal cord. In: Davidoff RA. Handbook of the Spinal Cord. New York: Marcel Dekker, 1987:559-606.**

Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992;8:338-45.

Hiz F, Kokes U, Eyiipgil T, Sari SO, Erdogan A. Akut transvers miyelite neden olan tersiyer spinal sifiliz tablosu: Olgu sunumu. [Acute transverse myelitis with tertiary spinal syphilis.] Turk Noroloji Dergisi 2008;14:121-7.

Hopkins IJ. A new syndrome: poliomyelitis-like illness associated with acute asthma in childhood. Aust Paediatr J 1974;10:273-6.

Hummers LK, Krishnan C, Casciola-Rosen L, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004;62:147-9.*

Interferon-Beta Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 1993;43:655-61.

Irani DN, Kerr DA. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000;355:901.

Jacob A, Nicholas R, Das K, et al. Exploring the relationship of relapsing myelitis with neuromyelitis optica (Devic's disease) and multiple sclerosis. Ann Neurol 2004;56(Suppl. 8):S33, A88.*

Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898-904.

Jaffe D, Freeman W. Spinal necrosis and softening of obscure origin. Arch Neurol Psychiatry 1943;49:683-707.**

Javed A, Balabanov R, Arnason BGW, et al. Minor Salivary gland inflammation in Devic’s disease and longitudinally extensive myelitis. Mult Scler 2008;14:809-14.

Javed A, Kelly T, Walsh R, Reder AT. Longitudinally extensive transverse myelitis: Treatment outcome of patients with features of Sjögren’s disease and positive NMO antibody. Ann Neurol 2006;60(Suppl 10):S38, M-13.**

Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993;50:532-5.**

Johnson KP, Brooks BR, Cohen JA, et al. Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology 1998;50:701-8.

Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis: clinical and immunologic studies. N Engl J Med 1984;310:137-41.**

Kahl KG, Naumann M, Oertele E, Warmuth-Metz M, Toyka KV. Recurrent transverse myelitis. 2 cases and review of the literature. Nervenarzt 1998;69:1115-22.

Kalita J, Misra UK, Mandal SK. Prognostic predictors of acute transverse myelitis. Acta Neurol Scand 1998;98:60-3.

Kalra V, Sharma S, Sahu J, et al. Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies. J Child Neurol 2009;24(4):466-71.

Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005;115:2731-41.

Karaszewski JW, Reder AT, Anlar B, Kim WC, Arnason BG. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. Ann Neurol 1991;30:42-7.

Kastenbauer S, Winkler F, Fesl G, et al. Acute severe spinal cord dysfunction in bacterial meningitis in adults. Arch Neurol 2001;58:806-10.

Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology 2002;58:143-6.*

Kennedy PG, Weir AI. Rapid recovery of acute transverse myelitis treated with steroids. Postgrad Med J 1988;64:384-5.

Kesselring J, Miller DH, Robb SA, et al. Acute disseminated encephalomyelitis: MRI findings and the distinctions from multiple sclerosis. Brain 1990;113:291-302.**

Kikuchi H, Osoegawa M, Ochi H, et al. Spinal cord lesions of myelitis with hyperIGEemia and mite antigen specific IgE (atopic myelitis) manifest eosinophilic inflammation. J Neuro Sci 2001;183:73-8.

Kim KK. Idiopathic recurrent transverse myelitis. Arch Neurol 2003;60:1290-4.

Kister I, Gulati S, Boz C, et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006;63:851-6.**

Knebusch M, Strassburg HM, Reiners K. Acute transverse myelitis in childhood: nine cases and review of the literature. Dev Med Child Neurol 1998;40:631-9.

Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.

Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004;63:33-9.

Kumar S, Sandhya G, Rajshekher G, Reddy R, Prabhakar S. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2008;70:160.

Krishnan C, Kaplin AI, Deshpande DM, et al. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci 2004;9:1483-99.

Label LS, Batts DH. Transverse myelitis caused by duck embryo rabies vaccine. Arch Neurol 1982;39:426-30.

Lehnhardt FG, Impekoven P, Rubbert A, et al. Recurrent longitudinal myelitis as primary manifestation of SLE. Neurology 2004:63:1976.**

Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12.

Li R, Qiu W, Lu Z, et al. Acute transverse myelitis in demyelinating diseases among the Chinese. J Neurol 2011; 258(12):2206-13.

Ligocki AJ, Rounds WH, Cameron EM, et al. Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. Genes Immun 2013;14(5):291-301.

Lindsey JW, Albers GW, Steinman L. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Ann Neurol 1992;32:407-9.

Lipton HL, Teasdall RD. Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 1973;28:252-7.**

Lubin JR, Loewenstein JI, Frederick AJ. Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol 1981;91:332-41.

Maimone D, Reder AT, Gregory S. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Cell Immunol 1993;146:96-106.

Marabani M, Zoma A, Hadley D, Sturrock RD. Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus. Ann Rheum Dis 1989;48:160-2.

Mastronardi L, Elsawaf A, Roperto R, et al. Prognostic relevance of the postoperative evolution of intramedullary spinal cord changes in signal intensity on magnetic resonance imaging after anterior decompression for cervical spondylotic myelopathy. J Neurosurg Spine 2007;7(6):615-22.

Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol 1987;22:714-23.**

Miller DH, Ormerod IC, Rudge P, Kendall BE, Moseley IF, McDonald WI. The early risk in multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 1989;26:635-9.

Miller HG, Stanton JB, Gibbons JL. Para-infectious encephalomyelitis and related syndromes. Q J Med 1956;25:427-505.

Mirich DR, Kucharczyk W, Keller MA, Deck J. Subacute necrotizing myelopathy: MR imaging in four pathologically proved cases. Am J Neuroradiol 1991;12:1077-83.

Miska RM, Pojunas KW, McQuillen MP. Cranial magnetic resonance imaging in the evaluation of myelopathy of undetermined etiology. Neurology 1987;37:840-3.

Misra UK, Kalita J. Can electromyography predict the prognosis of transverse myelitis? J Neurol 1998;245(11):741-4.

Miyazawa R, Ikeuchi Y, Tomomasa T, Ushiku H, Ogawa T, Morikawa A. Determinants of prognosis of acute transverse myelitis in children. Pediatr Int 2003;45:512-6.

Moersch FP, Kernohan JW. Progressive necrosis of the spinal cord. Arch Neurol Psychiatry 1934;31:504.

Montalban X, Duran I, Rio J, Saez-Torres I, Tintore M, Martinez-Caceres EM. Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta? J Neurol 2000;247:259-62.

Motomura S, Tabira T, Kuroiwa Y. A clinical comparative study of multiple sclerosis and neuro-Behçet’s syndrome. J Neurol Neurosurg Psychiatry 1980;43:210-3.

Nagahama Y, Shimohama S, Kaji R, Akiguchi I, Kimura J. An adult case of transverse myelitis with erythema infectiosum. Rinsho Shinkeigaku 1992;32:1035-7.

Nakajima H, Furutama D, Kimura F, et al. Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 1998;39:163-7.

Nakashima I, Fujihara K, Takase S, Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 1999;188:89-94.

Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006;63:1113-20.

Ojeda VJ. Necrotizing myelopathy associated with malignancy. Cancer 1984;53:1115-23.**

Okuda DT, Melmed K, Matsuwaki T, Blomqvist A, Craig AD. Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions. Annals of Clinical and Translational Neurology 2014;1(8):554-61.**

Paine RS, Byers RK. Transverse myelopathy in childhood. Am J Dis Child 1953;85:151-63.**

Pandit L, Rao S. Recurrent myelitis. J Neurol Neurosurg Psychiatry 1996;60:336-8.

Panitch HS, Bever CT Jr, Katz E, Johnson KP. Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon. J Neuroimmunol 1991;Suppl 1:125.**

Pardatscher K, Fiore DL, Lavano A. MR imaging of transverse myelitis using Gd-DTPA. J Neuroradiol 1992;19:63-7.

Paty DW, Blume WT, Brown WF, et al. Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan. Ann Neurol 1978;6:419-24.**

Perez-Montes R, Richard C, Baro J, Pascual J, Varela R, Zubizarreta A. Acute transverse myelitis and autoimmune pancytopenia after unrelated hematopoietic cell transplantation. Haematologica 2001;86:556-7.

Perumal J, Zabad R, Caon C, et al. Acute transverse myelitis with normal brain MRK: Long-term risks of multiple sclerosis. J Neurol 2008;255:89-93.

Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol 2006;19:362-8.

Plum F, Olson ME. Myelitis and myelopathy. In: Baker AB, Baker LH, editors. Clinical neurology. Philadelphia: 1973:1-49.

Poser CM. Magnetic resonance imaging in asymptomatic disseminated vasculomyelinopathy. J Neurol Sci 1989;94:69-77.

Pradhan S, Gupta RK, Kapoor R, et al. Parainfectious conus myelitis. J Neurol Sci 1998;161:156-62.

Ravaglia S, Bastianello S, Franciotta D, et al. NMO-IgG-negative relapsing myelitis. Spinal Cord 2009;47(7):531-7.

Reder AT, Thapar M, Jensen M. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 1994;44:2289-94.

Richter RW, Pearson J, Bruun B, Challenor YB, Brust JC, Baden MM. Neurological complications of addiction to heroin. Bull N Y Acad Med 1973;49:3-21.

Roos KL. Acute severe spinal cord dysfunction in bacterial meningitis in adults. Arch Neurol 2001;58:717-8.

Ropper A, Miett T, Chiappa K. Absence of evoked potential abnormalities in acute transverse myelopathy. Neurology 1982;32:80-2.

Ropper AH, Poskanzer DC. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978;4:51-9.

Ross AG, McManus DP, Farrar J, Hunstman RJ, Gray DJ, Li YS. Neuroschistosomiasis. J Neurol 2012;259(1):22-32.

Rowe A, Gorman WP. Transverse myelitis and myelography. Bristol Med Chir J 1986;101:58-9.

Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the spinal cord, nerve, and muscle. Muscle Nerve 2000;23:1800-18.**

Sadowsky CL, Becker D, Bosques G, et al. Rehabilitation in transverse myelitis. Continuum (Minneap Minn) 2011;17(4):816-30.**

Sanders KA, Khandji AG, Mohr JP. Gadolinium-MRI in acute transverse myelopathy. Neurology 1990;40:1614-6.

Satoh JI, Yukitake M, Kurohara K, Takashima H, Kuroda Y. Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis. J Neurol Sci 2003;212:11-20.

Scott TF. Nosology of idiopathic transverse myelitis syndromes. Acta Neurol Scand 2007;115:371-6.

Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis. Neurology 1998;50:429-33.

Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 2005;11:373-7.

Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 2006;63:1398-1400.*

Seifert T, Enzinger C, Ropele S, Storch MK, Strasser-Fuchs S, Fazekas F. Relapsing acute transverse myelitis: a specific entity. Eur J Neurol 2005;12:681-4.

Sellner J, Luthi N, Buhler R, et al. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol 2008;15:398-405.

Shyu WC, Lin JC, Chang BC, Harn HJ, Lee CC, Tsao WL. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection. Ann Neurol 1993;34:625-7.

Simnad VI, Pisani DE, Rose JW. Multiple sclerosis presenting as transverse myelopathy: clinical and MRI features. Neurology 1997;48:65-73.

Stubgen JP. Immune-mediated myelitis associated with hepatitis virus infections. J Neuroimmunol 2011;239(1-2):21-7.

Suri A, Chabbra RP, Mehta VS, Gaikwad S, Pandey RM. Effect of intramedullary signal changes on the surgical outcome of patients with cervical spondylotic myelopathy. Spine J 2003;3(1):33-45.

Tartaglino LM, Croul SE, Flanders AE, et al. Idiopathic acute transverse myelitis: MR imaging findings. Radiology 1996;201:661-9.

Tartaglino LM, Heiman-Patterson T, Friedman DP, Flanders AE. MR imaging in a case of postvaccination myelitis. AJNR Am J Neuroradiol 1995;16:581-2.

Thomas T, Branson HM, Verhey LH, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol 2012;27(1):11-21.

Tippett DS, Fishman PS, Panitch HS. Relapsing transverse myelitis. Neurology 1991;41:703-6.

Tosi L, Rigoli G, Beltramello A. Fibrocartilaginous embolism of the spinal cord: a clinical and pathogenetic reconsideration. J Neurol Neurosurg Psychiatry 1996;60:55-60.

Ungurean A, Palfi S, Dibo G, Tiszlavicz L, Vecsei L. Chronic recurrent transverse myelitis or multiple sclerosis. Funct Neurol 1996;11(4):209-14.

Wilmshurst JM, Walker MC, Pohl KR. Rapid onset transverse myelitis in adolescence: implications for pathogenesis and prognosis. Arch Dis Child 1999;80:137-42.

Wulff CH. Evoked potentials in acute transverse myelopathy. Dan Med Bull 1985;32:282-6.

Yamada S, Hoshi A, Takai Y, et al. Radiation tolerance dose of the spinal cord following conventionally fractionated irradiation. Gan No Rinsho 1987;33:1189-92.

Yiu EM, Kornberg AJ, Ryan MM, Coleman LT, Mackay MT. Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities? J Child Neurol 2009;24(3):287-96.

Yoon JH, Joo IS, Li WY, Sohn SY. Clinical and laboratory characteristics of atopic myelitis: Korean experience. J Neurol Sci 2009;285(1-2):154-8.

Young J, Quinn S, Hurrell M, Taylor B. Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 2009;15(11):1295-302.

Ziegler DK. Acute disseminated encephalitis. Some therapeutic and diagnostic considerations. Arch Neurol 1966;14:476-88.

**References especially recommended by the author or editor for general reading.

In This Article

Introduction
Historical note and nomenclature
Clinical manifestations
Clinical vignette
Etiology
Pathogenesis and pathophysiology
Epidemiology
Prevention
Differential diagnosis
Diagnostic workup
Prognosis and complications
Management
Pregnancy
Anesthesia
References cited
Contributors